SAPHNELO: payments to doctors
Payments that named SAPHNELO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $11.2M
- Providers
- 6,622
- Transactions
- 70,442
- Average per transaction
- $160
The per-transaction average — $160 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,622 providers the average total is $1,698, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $9,866,549 | 87.7% |
| Astrazeneca UK Limited | $1,378,411 | 12.3% |
| Acerta Pharma LLC | $232 | 0.0% |